Proclemer Alessandro, Zecchin Massimo, Lunati Maurizio, Rebellato Luca, Ghidina Marco, Bianco Giulia, Bernardelli Emanuela, Pucher Elsa, Gregori Dario
G Ital Cardiol (Rome). 2013 Nov;14(11):784-96. doi: 10.1714/1360.15091.
The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) Registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2012 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.
The Registry collects prospectively national PM and ICD implantation activity on the basis of European cards.
PM Registry: data about 25 611 PM implantations were collected (18 870 first implant and 6741 replacements). The number of collaborating centers was 245. Median age of treated patients was 80 years (74 quartile I; 86 quartile III). ECG indications included atrioventricular conduction disorders in 41.9% of first PM implants, sick sinus syndrome in 26.0%, atrial fibrillation plus bradycardia in 13.7%, other in 18.4%. Among atrioventricular conduction defects, third-degree atrioventricular block was the most common type (21.7% of first implants). Use of single-chamber PMs was reported in 29.0% of first implants, of dual-chamber PMs in 61.3%, of PMs with cardiac resynchronization therapy (CRT) in 1.7%, and of single lead atrial-synchronized ventricular stimulation (VDD/R PMs) in 8.0%. ICD REGISTRY: data about 16 606 ICD implantations were collected (11 393 first implants and 5213 replacements). The number of collaborating centers was 427. Median age of treated patients was 71 years (62 quartile I; 77 quartile III). Primary prevention indication was reported in 68.6% of first implants, secondary prevention in 31.4% (cardiac arrest in 9.0%). A single-chamber ICD was used in 29.4% of first implants, dual-chamber in 37.6% and biventricular in 32.9%.
The PM and ICD Registry appears fundamental for monitoring PM and ICD utilization on a large national scale with rigorous examination of demographics and clinical indications. The PM Registry showed stable electrocardiographic and symptom indications, with an important prevalence of dual-chamber pacing. The use of CRT-PM regards a very limited number of patients. The ICD Registry documented a constant increase in prophylactic and biventricular ICD use, reflecting a favorable adherence to trials and guidelines in clinical practice.
意大利心律失常与心脏起搏协会(AIAC)的起搏器(PM)和植入式心律转复除颤器(ICD)注册登记处监测实际临床中的主要流行病学数据。2012年活动调查从意大利合作中心收集了有关人口统计学、临床特征、PM/ICD治疗主要适应证及设备类型的信息。
该注册登记处基于欧洲卡片前瞻性收集全国PM和ICD植入活动的数据。
PM注册登记处:收集到25611例PM植入数据(18870例首次植入和6741例更换)。合作中心数量为245个。接受治疗患者的中位年龄为80岁(四分位数I为74岁;四分位数III为86岁)。心电图适应证方面,首次PM植入中41.9%为房室传导障碍,26.0%为病态窦房结综合征,13.7%为心房颤动合并心动过缓,18.4%为其他情况。在房室传导缺陷中,三度房室传导阻滞是最常见类型(首次植入的21.7%)。首次植入中29.0%报告使用单腔PM,61.3%使用双腔PM,1.7%使用心脏再同步治疗(CRT)的PM,8.0%使用单导联心房同步心室刺激(VDD/R PM)。ICD注册登记处:收集到16606例ICD植入数据(11393例首次植入和5213例更换)。合作中心数量为427个。接受治疗患者的中位年龄为71岁(四分位数I为62岁;四分位数III为77岁)。首次植入中68.6%为一级预防适应证,31.4%为二级预防(心脏骤停占9.0%)。首次植入中29.4%使用单腔ICD,37.6%使用双腔ICD,32.9%使用双心室ICD。
PM和ICD注册登记处对于在全国范围内大规模监测PM和ICD的使用情况、严格审查人口统计学和临床适应证似乎至关重要。PM注册登记处显示心电图和症状适应证稳定,双腔起搏占重要比例。CRT-PM的使用涉及患者数量非常有限。ICD注册登记处记录了预防性和双心室ICD使用的持续增加,反映出临床实践中对试验和指南的良好遵循情况。